iRhythm Technologies, Inc. (IRTC) is a Medical - Devices company in the Healthcare sector, currently trading at $123.23. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of IRTC = $1,387.90 (+1026.3% from the current price, the stock appears undervalued). Analyst consensus target is IRTC = $211 (+71.2% upside).
Valuation: IRTC trades at a trailing Price-to-Earnings (P/E) of -85.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.22.
Financials: revenue is $747M, +22.1%/yr average growth. Net income is $45M (loss), growing at +20.9%/yr. Net profit margin is -6% (negative). Gross margin is 70.6% (+2.1 pp trend).
Balance sheet: total debt is $731M against $153M equity (Debt-to-Equity (D/E) ratio 4.79, leveraged). Current ratio is 4.63 (strong liquidity). Debt-to-assets is 71.7%. Total assets: $1.0B.
Analyst outlook: 16 / 19 analysts rate IRTC as buy (84%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 100/100 (Pass), Past 0/100 (Fail), Health 33/100 (Fail), Moat 70/100 (Pass), Future 94/100 (Pass), Income 10/100 (Fail).
